Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification

Davis, J, Desmond, M and Berk, Michael 2018, Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification, BMC nephrology, vol. 19, pp. 1-7, doi: 10.1186/s12882-018-1101-4.

Attached Files
Name Description MIMEType Size Downloads

Title Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification
Author(s) Davis, J
Desmond, M
Berk, MichaelORCID iD for Berk, Michael orcid.org/0000-0002-5554-6946
Journal name BMC nephrology
Volume number 19
Article ID 305
Start page 1
End page 7
Total pages 7
Publisher BioMed Central
Place of publication London, Eng.
Publication date 2018-11-03
ISSN 1471-2369
Keyword(s) lithium
chronic kidney disease
nephrotoxicity
nephrogenic diabetes insipidus
science & technology
life sciences & biomedicine
urology & nephrology
Summary BACKGROUND: Despite lithium being the most efficacious treatment for bipolar disorder, its use has been decreasing at least in part due to concerns about its potential to cause significant nephrotoxicity. Whilst the ability of lithium to cause nephrogenic diabetes insipidus is well established, its ability to cause chronic kidney disease is a much more vexing issue, with various studies suggesting both positive and negative causality. Despite these differences, the weight of evidence suggests that lithium has the potential to cause end stage kidney disease, albeit over a prolonged period. METHODS: A search strategy for this review was developed to identify appropriate studies, sourced from the electronic databases EMBASE, PubMed (NLM) and MEDLINE. Search terms included lithium with the AND operator to combine with nephrotoxicity or nephropathy or chronic kidney disease or nephrogenic diabetes insipidus or renal and pathophysiology. RESULTS: The risks for the development of lithium induced nephropathy are less well defined but appear to include the length of duration of therapy as well as increasing age, as well as episodes of over dosage/elevated lithium levels. Whilst guidelines exist for the routine monitoring of lithium levels and renal function, it remains unclear when nephrological evaluation should occur, as well as when cessation of lithium therapy is appropriate balancing the significant attendant mental health risks as well as the potential for progression to occur despite cessation of therapy against the risks and morbidity of bipolar disorder itself. CONCLUSION: This paper will elucidate on the current evidence pertaining to the topic of the clinical management of lithium induced nephrotoxicity and provide a guide for clinicians who are faced with the long-term management of these patients.
Language eng
DOI 10.1186/s12882-018-1101-4
Field of Research 1103 Clinical Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2018, The Authors
Persistent URL http://hdl.handle.net/10536/DRO/DU:30115673

Document type: Journal Article
Collections: School of Medicine
Open Access Checking
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 6 Abstract Views, 2 File Downloads  -  Detailed Statistics
Created: Tue, 27 Nov 2018, 09:28:57 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.